MedTrace Logo

Evaluation of a Resiliency Intervention for Siblings of Children With Autism Spectrum Disorder (ASD)

NCT04369417 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2022-04-05

No results posted yet for this study

Summary

The proposed research has the following objectives:

Based off findings from the "Development of a Resiliency Program for Siblings of Children with Autism Spectrum Disorder" qualitative focus group study (protocol 2019P002284), the aim is to determine the feasibility and acceptability, of an 8-session Relaxation Response Resiliency (SibChat) program for siblings of children with ASD.

We primarily aim to test the preliminary effectiveness of a pilot waitlist controlled trial on improving resiliency and stress coping, This will be assessed by comparing Baseline-3 mo. scores on primary and secondary outcome measures between the Immediate and Waitlist control groups.

Among participants randomized to both conditions, we secondarily aim to investigate the extent of pre-post changes in primary and secondary outcomes. Among immediate condition group only, we also aim to assess whether end-of-treatment (3 mo. post enrollment) improvements will be sustained at 6-mo. post enrollment.

Conditions

  • Stress

Interventions

BEHAVIORAL

Relaxation Response Resiliency Program for Siblings of Children with ASD

Virtually delivered psycho-educational resiliency training program for teenage siblings of children with ASD.

Sponsors & Collaborators

  • Health Resources and Services Administration (HRSA)

    collaborator FED

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Karen A Kuhlthau, PhD · Massachusetts General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
14 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-28
Primary Completion
2021-01-01
Completion
2021-01-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04369417 on ClinicalTrials.gov